Onkológia 3/2008

WHAT ARE WE ABLE TO ACHIEVE IN THE TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER TODAY?

Several metaanalyses published in the beginning of the 1990s confirmed effectivity of chemotherapy in comparison with best supportive care in advanced/metastatic non-small cell lung cancer: the median survival time was prolonged by 6 weeks - 2 months, and the number of patients surviving one year increased by about 10%. Influence of these metaanalyses on perception of non-small cell lung cancer chemotherapy as an indicated but less effective treatment continues until today in some extend. Image of the advanced non-small cell lung cancer treatment has improved during the last years markedly, mainly due to new treatment possibilities discussed in this case report.

Keywords: non-small cell lung cancer, chemotherapy, targeted therapy